Home LiteratureArticle Details
PMID: 8627686 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Journal of virology ·Vol. 70 ·No. 3 ·1996-03-00 ·Pages 1651-67

Gao F, Morrison SG, Robertson DL, Thornton CL, Craig S, Karlsson G, Sodroski J, Morgado M, Galvao-Castro B, von Briesen H, Beddows S, Weber J, Sharp PM, Shaw GM, Hahn BH

Abstract

Present knowledge of human immunodeficiency virus type 1 (HIV-1) envelope immunobiology has been derived almost exclusively from analyses of subtype B viruses, yet such viruses represent only a minority of strains currently spreading worldwide. To generate a more representative panel of genetically diverse envelope genes, we PCR amplified, cloned, and sequenced complete gp160 coding regions of 35 primary (peripheral blood mononuclear cell-propagated) HIV-1 isolates collected at major epicenters of the current AIDS pandemic. Analysis of their deduced amino acid sequences revealed several important differences from prototypic subtype B strains, including changes in the number and distribution of cysteine residues, substantial length differences in hypervariable regions, and premature truncations in the gp41 domain. Moreover, transiently expressed glycoprotein precursor molecules varied considerably in both size and carbohydrate content. Phylogenetic analyses of full-length env sequences indicated that the panel included members of all major sequence subtypes of HIV-1 group M (clades A to G), as well as an intersubtype recombinant (F/B) from an infected individual in Brazil. In addition, all subtype E and three subtype G viruses initially classified on the basis of partial env sequences were found to cluster in subtype A in the 3' half of their gp41 coding region, suggesting that they are also recombinant. The biological activity of PCR-derived env genes was examined in a single-round virus infectivity assay. This analysis identified 20 clones, including 1 from each subtype (or recombinant), which expressed fully functional envelope glycoproteins. One of these, derived from a patient with rapid CD4 cell decline, contained an amino acid substitution in a highly conserved endocytosis signal (Y721C), as mediated virus entry with very poor efficiency, although they did not contain sequence changes predicted to alter protein function. These results indicate that the env genes of primary HIV-1 isolates collected worldwide can vary considerably in their genetic, phylogenetic, and biological properties. The panel of env constructs described here should prove valuable for future structure-function studies of naturally occurring envelope glycoproteins as well as AIDS vaccine development efforts targeted against a broader spectrum of viruses.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Cloning, Molecular DNA, Viral Gene Expression/drug effects Gene Products, env/genetics,physiology Genes, rev Genes, tat HIV Envelope Protein gp120/genetics,physiology HIV Envelope Protein gp160 HIV Envelope Protein gp41/genetics,physiology HIV Infections/virology HIV-1/classification,genetics,isolation & purification HeLa Cells Humans Molecular Sequence Data Phylogeny Polymerase Chain Reaction Protein Precursors/genetics,physiology Recombination, Genetic Sequence Homology, Amino Acid Sequence Homology, Nucleic Acid Tunicamycin/pharmacology
Chemicals
DNA, Viral Gene Products, env HIV Envelope Protein gp120 HIV Envelope Protein gp160 HIV Envelope Protein gp41 Protein Precursors Tunicamycin
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Gao F
Department of Medicine, University of Alabama at Birmingham 35294, USA.
Morrison S G
Robertson D L
Thornton C L
Craig S
Karlsson G
Sodroski J
Morgado M
Galvao-Castro B
von Briesen H
Beddows S
Weber J
Sharp P M
Shaw G M
Hahn B H
References (93)
93 references, click to expand
  1. Multiple aligned sequence editor (MASE).
    Trends Biochem Sci. 1988 Aug;13(8):321-2 PMID: 3154283
  2. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors.
    J Acquir Immune Defic Syndr. 1994 Jan;7(1):68-73 PMID: 7903381
  3. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic.
    AIDS Res Hum Retroviruses. 1993 Oct;9(10):997-1006 PMID: 8280481
  4. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype.
    J Infect Dis. 1994 Feb;169(2):281-8 PMID: 8106761
  5. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.
    J Virol. 1994 Mar;68(3):1581-5 PMID: 8107219
  6. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.
    J Virol. 1994 Mar;68(3):1586-96 PMID: 8107220
  7. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses.
    J Virol. 1994 Apr;68(4):2161-8 PMID: 8139000
  8. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.
    AIDS. 1993 Nov;7 Suppl 2:S65-71 PMID: 7909227
  9. Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire.
    AIDS. 1994 Jan;8(1):21-6 PMID: 8011235
  10. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells.
    J Virol. 1994 Aug;68(8):4857-61 PMID: 8035484
  11. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.
    Nature. 1994 Aug 11;370(6489):463-7 PMID: 8047166
  12. Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data.
    AIDS. 1994 May;8(5):619-24 PMID: 8060542
  13. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil.
    J Virol. 1994 Oct;68(10):6340-6 PMID: 8083973
  14. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.
    J Virol. 1994 Oct;68(10):6730-44 PMID: 8084005
  15. NIH conference. HIV vaccine development: a progress report.
    Ann Intern Med. 1994 Oct 15;121(8):603-11 PMID: 8085693
  16. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F.
    AIDS Res Hum Retroviruses. 1994 May;10(5):569-76 PMID: 7522493
  17. HIV-1 sequence subtype D in the United States.
    AIDS Res Hum Retroviruses. 1994 May;10(5):625-7 PMID: 7917525
  18. A review of human immunodeficiency virus infection in India.
    J Acquir Immune Defic Syndr. 1994 Nov;7(11):1185-94 PMID: 7932085
  19. Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    J Med Primatol. 1994 Feb-May;23(2-3):184-225 PMID: 7966234
  20. The WHO and why of HIV vaccine trials.
    Nature. 1994 Nov 24;372(6504):313-4 PMID: 7969482
  21. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group.
    Virology. 1994 Nov 15;205(1):247-53 PMID: 7975221
  22. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
    J Virol. 1995 Jan;69(1):101-9 PMID: 7527081
  23. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin.
    J Virol. 1995 Jan;69(1):263-71 PMID: 7983718
  24. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
    Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 PMID: 7984417
  25. Genetic and phylogenetic analysis of env subtypes G and H in central Africa.
    AIDS Res Hum Retroviruses. 1994 Jul;10(7):877-9 PMID: 7986593
  26. Presence in India of HIV type 1 similar to North American strains.
    AIDS Res Hum Retroviruses. 1994 Aug;10(8):1039-41 PMID: 7811535
  27. Genotypic subtypes of HIV-1 in Cameroon.
    AIDS. 1994 Oct;8(10):1405-12 PMID: 7818811
  28. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.
    AIDS. 1994 Nov;8(11):1622-3 PMID: 7848602
  29. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
    AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S201-5 PMID: 7865301
  30. Scientific and social issues of human immunodeficiency virus vaccine development.
    Science. 1993 May 28;260(5112):1279-86 PMID: 8493572
  31. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.
    J Virol. 1993 Jul;67(7):3712-9 PMID: 8389902
  32. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes.
    AIDS. 1993 Jun;7(6):769-80 PMID: 8363755
  33. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire.
    AIDS Res Hum Retroviruses. 1993 Jul;9(7):613-8 PMID: 8369166
  34. Role of the cytoplasmic domains of viral glycoproteins in antibody-induced cell surface mobility.
    J Virol. 1993 Oct;67(10):6289-94 PMID: 8396682
  35. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9061-5 PMID: 8415653
  36. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.
    Science. 1993 Nov 19;262(5137):1257-61 PMID: 8235655
  37. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.
    J Immunol. 1995 Jul 1;155(1):473-88 PMID: 7602119
  38. HIV vaccines. Back to primary school.
    Nature. 1995 Jul 13;376(6536):115 PMID: 7603556
  39. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells.
    J Virol. 1995 Sep;69(9):5217-27 PMID: 7636963
  40. Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France.
    J Virol. 1995 Sep;69(9):5640-9 PMID: 7637010
  41. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    J Virol. 1995 Sep;69(9):5723-33 PMID: 7543586
  42. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.
    J Virol. 1995 Oct;69(10):6122-30 PMID: 7666516
  43. Yet another subtype of HIV type 1?
    AIDS Res Hum Retroviruses. 1995 Aug;11(8):995-7 PMID: 7492448
  44. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants.
    AIDS. 1995 Jul;9(7):685-90 PMID: 7546411
  45. Candidate AIDS vaccines.
    N Engl J Med. 1995 Nov 16;333(20):1331-9 PMID: 7566026
  46. Protecting HIV databases.
    Nature. 1995 Nov 16;378(6554):242-4 PMID: 7477340
  47. Identification of HIV-1 subtype G from Uganda.
    AIDS Res Hum Retroviruses. 1995 May;11(5):657-9 PMID: 7576924
  48. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.
    J Virol. 1996 Jan;70(1):445-58 PMID: 8523557
  49. Cross-species transmission and recombination of 'AIDS' viruses.
    Philos Trans R Soc Lond B Biol Sci. 1995 Jul 29;349(1327):41-7 PMID: 8748018
  50. Heterogeneity of HIV-1 and HIV-2.
    AIDS. 1995;9 Suppl A:S5-18 PMID: 8819565
  51. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.
    AIDS. 1995;9 Suppl A:S117-36 PMID: 8819579
  52. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.
    J Mol Evol. 1980 Dec;16(2):111-20 PMID: 7463489
  53. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.
    Cell. 1986 Jul 4;46(1):63-74 PMID: 2424612
  54. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6 PMID: 3095828
  55. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
    J Virol. 1987 Feb;61(2):570-8 PMID: 2433466
  56. Preparations for AIDS vaccine evaluations. Rate of new HIV infection in a cohort of women of childbearing age in Malawi.
    AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S239-41 PMID: 7865310
  57. Preparatory studies for possible HIV vaccine trials in northern Thailand.
    AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S243-6 PMID: 7865311
  58. New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection.
    AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S61-6 PMID: 7865335
  59. Recombination in HIV-1.
    Nature. 1995 Mar 9;374(6518):124-6 PMID: 7877682
  60. Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus.
    AIDS. 1994 Dec;8(12):1649-55 PMID: 7888112
  61. Tenth anniversary perspectives on AIDS. HIV: between past and future.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1317-24 PMID: 7888185
  62. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO Network for HIV Isolation and Characterization.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1355-8 PMID: 7888188
  63. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1359-68 PMID: 7888189
  64. Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world. WHO Network for HIV Isolation and Characterization.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1401-8 PMID: 7888193
  65. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1543-50 PMID: 7888209
  66. Early HIV type 1 strains in Thailand were not responsible for the current epidemic.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1573-5 PMID: 7888212
  67. Genetic variability of HIV type 1 in Kenya.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1577-9 PMID: 7888213
  68. Subgroup G HIV type 1 isolates from Nigeria.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1581-3 PMID: 7888214
  69. HIV-1 subtypes and male-to-female transmission in Thailand.
    Lancet. 1995 Apr 29;345(8957):1078-83 PMID: 7715340
  70. Recombination in AIDS viruses.
    J Mol Evol. 1995 Mar;40(3):249-59 PMID: 7723052
  71. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
    J Virol. 1995 Jun;69(6):3824-30 PMID: 7745730
  72. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.
    J Virol. 1995 Jul;69(7):4413-22 PMID: 7769703
  73. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.
    J Virol. 1991 Aug;65(8):3973-85 PMID: 1830110
  74. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.
    J Virol. 1992 Feb;66(2):875-85 PMID: 1731112
  75. Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1.
    J Acquir Immune Defic Syndr. 1992;5(5):441-9 PMID: 1560340
  76. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
    J Virol. 1992 Jun;66(6):3306-15 PMID: 1583717
  77. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling.
    Protein Eng. 1992 Jan;5(1):35-41 PMID: 1631044
  78. Structural variability of env and gag gene products from a highly cytopathic strain of HIV-1.
    Arch Virol. 1992;125(1-4):287-98 PMID: 1642554
  79. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.
    J Virol. 1992 Nov;66(11):6616-25 PMID: 1357190
  80. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.
    J Virol. 1993 Jan;67(1):213-21 PMID: 8416370
  81. Genetic variants of HIV-1 in Thailand.
    AIDS Res Hum Retroviruses. 1992 Nov;8(11):1887-95 PMID: 1489577
  82. HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate.
    AIDS. 1993 Jan;7(1):23-7 PMID: 8442916
  83. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Science. 1993 Mar 19;259(5102):1749-54 PMID: 8096089
  84. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand.
    Lancet. 1993 May 8;341(8854):1171-4 PMID: 8098076
  85. The neighbor-joining method: a new method for reconstructing phylogenetic trees.
    Mol Biol Evol. 1987 Jul;4(4):406-25 PMID: 3447015
  86. Rates and dates of divergence between AIDS virus nucleotide sequences.
    Mol Biol Evol. 1988 Jul;5(4):313-30 PMID: 3405075
  87. Fast and sensitive multiple sequence alignments on a microcomputer.
    Comput Appl Biosci. 1989 Apr;5(2):151-3 PMID: 2720464
  88. Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus.
    Gene. 1989 Sep 30;81(2):275-84 PMID: 2806917
  89. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
    N Engl J Med. 1989 Dec 14;321(24):1621-5 PMID: 2586564
  90. Automatic generation of primary sequence patterns from sets of related protein sequences.
    Proc Natl Acad Sci U S A. 1990 Jan;87(1):118-22 PMID: 2296575
  91. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.
    J Virol. 1990 May;64(5):2416-20 PMID: 2325207
  92. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
    J Biol Chem. 1990 Jun 25;265(18):10373-82 PMID: 2355006
  93. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
    J Virol. 1990 Dec;64(12):5701-7 PMID: 2243375
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-03-00
Pages
1651-67
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC189989
Subset
IM
Grants
NIAID NIH HHS · N01AI35170 · United States
NIAID NIH HHS · P30 AI27767 · United States
NIAID NIH HHS · R01AI25291 · United States
Databases
GENBANK
L34667, U04900, U04901, U04902, U04903, U04904, U04905, U04906, U04907, U04908, U04909, U04910, U04911, U04912, U04913, U04914, U04915, U04916, U04917, U04918, U04919, U04920, U04921, U04922, U04923, U04924, U04925, U04926, U04927, U04928
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com